The company's upbeat forecast follows that of industry
bellwether UnitedHealth Group Inc, which said although demand
for deferred procedures was approaching normal levels it had
still not increased as feared, leading to lower claims and
costs.
In the first quarter, Anthem's benefit expense ratio - an
insurer's spending on claims against the premiums it earns - was
86.1%, compared with expectations of 87.8%, according to five
analysts polled by Refinitiv.
The company now expects adjusted net income of over $28.40 per
share, compared with its prior forecast of more than $28.25 per
share.
Excluding items, Anthem earned $8.25 per share, surging past
Refinitiv IBES estimates of $7.81 per share.
Net income attributable to shareholders rose to $1.81 billion,
or $7.39 per share, in the first quarter ended March 31 from
$1.67 billion, or $6.71 per share, a year earlier.
(Reporting by Manas Mishra in Bengaluru; Editing by Anil D'Silva)
[© 2022 Thomson Reuters. All rights
reserved.]
Copyright 2022 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|